SITC's Cancer Immunotherapy Guidelines program is a collection of clinical practice guidelines (CPGs) developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and...
Depending on a variety of factors, there are various options for the treatment of genitourinary cancers (included bladder, kidney, and prostate cancers) including immunotherapy. This guide, published by Patient Resource Publishing in partnership with the Society for Immunotherapy of Cancer (SITC...
2020_Immuno_GU.pdf
On Thursday, January 13, 2022, 12:30-1:30 p.m. EST , join leading experts from the SITC Head and Neck Squamous Cell Carcinoma (HNSCC) Immunotherapy Guideline Expert Panel for "Practical Management Pearls for Immunotherapy for the Treatment of HNSCC – SITC CPG Webinar." This high-level webinar is...
01-13-2022 | 12:30 - 13:30 ET
On October 13, 2021, leading experts from the SITC Immune Effector Cell-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Case Studies in Immune Effector Cell-related Adverse Events." This high-level webinar covered advanced concepts of...
2 attachments
On October 6, 2021, leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar covered advanced...
On September 16, 2021, leading experts from the SITC Immune Checkpoint Inhibitor-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events." This high-level webinar...
On August 12, 2021, leading experts from the SITC Immune Effector Cell-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Effector Cell-related Adverse Events." This high-level webinar covered advanced...
On August 13, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events" during a live webinar. The recorded webinar and presentation...
On April 23, 2021, leading experts in cancer immunotherapy presented an adv anced webinar focused on "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma." This webinar was designed for attendees to be able to appraise and classify...
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - Los Angeles, CA held virtually on May 5, 2021 are available here. Program Organizers Edward B. Garon, MD – University of California Los Angeles Blanca A. Ledezma, NP – Ronald Reagan...
22 attachments
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us